Service description

The Accrual to Clinical Trials (ACT) Network is a real-time platform allowing researchers to explore and validate feasibility for clinical studies. The network contains de-identified data from over 100 million patients from academic medical research centers in the Clinical and Translational Science Award (CTSA) network. ACT is secure, HIPAA-compliant and IRB-approved. To learn more or see who is participating, visit the website:

Benefits to users

Using ACT, researchers can explore patient populations, confirm and demonstrate study feasibility, and identify potential partners for multi-site studies.

How to get access

Select “Register for ACT” on the ACT website:

Related documents


Once registered, all informatics tools are self-service and free to USC researchers, with an option to purchase additional services.

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.